Fibrous Dysplasia of Bone clinical trials
The registry lists 24 studies for Fibrous Dysplasia of Bone across 9 countries. 6 are recruiting or about to start. 7 of them are mainly about Fibrous Dysplasia of Bone (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Fibrous Dysplasia, Polyostotic too: 30 studies, 6 open.
Get an email when these change. Save the Fibrous Dysplasia of Bone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Hospices Civils de Lyon (8) · National Institute of Dental and Craniofacial Research (NIDCR) (6) · Latakia University (1) · Natasha Appelman-Dijkstra (1) · Istituto Ortopedico Rizzoli (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Boston Children's Hospital (1) · Yale University (1)
What is being tested here
Drugs under test in Fibrous Dysplasia of Bone studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Denosumab | 1 | 0 | 3 |
| Burosumab | 0 | 0 | 1 |
| Tocilizumab | 0 | 0 | 1 |
| Risedronic Acid | 0 | 1 | 1 |
| Letrozole | 0 | 0 | 1 |
| Anastrozole | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Nov 2026Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction. · Latakia University
- Jan 2027Fibrous Dysplasia: An Epidemiological and Correlational Evaluation of Multimodal Data · Istituto Ortopedico Rizzoli
Who these studies take
Of the 6 Fibrous Dysplasia of Bone studies recruiting now, 3 (50%) set no upper age limit and 1 (17%) stop at 75 or younger. 3 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (50%) | 3 (50%) |
| 18 | 6 (100%) | 6 (100%) |
| 30 | 6 (100%) | 6 (100%) |
| 40 | 6 (100%) | 6 (100%) |
| 50 | 6 (100%) | 6 (100%) |
| 65 | 5 (83%) | 5 (83%) |
| 75 | 5 (83%) | 5 (83%) |
| 85 | 5 (83%) | 5 (83%) |
Across all 24 studies, recruiting or not: 21% stop at 75 or younger and 21% at 65; 50% take children; 8% are for women only and 0% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 24 of 24. search them.
- Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright SyndromeRecruitingNCT000017271 country
- Fibrous Dysplasia: An Epidemiological and Correlational Evaluation of Multimodal DataRecruitingNCT075697311 country
- Clinical Evaluation of Patient-Specific 3D-Printed Titanium Implants for Facial Reconstruction.RecruitingNCT07654647Not applicable1 country
- Fibrous Dysplasia, McCune-Albright Syndrome Patient RegistryRecruitingNCT032316441 country
- DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)RecruitingNCT05966064Phase 41 country
- Hepato-pancreato-biliary Abnormalities in Fibrous Dysplasia of Bone/McCune Albright SyndromeRecruitingNCT061773271 country
- Pain in Fibrous DysplasiaCompletedNCT04125862Not applicable1 country
- PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot StudyCompletedNCT07476768Not applicable1 country
- Assessment of Femoral Failure Load and Fracture Risk in Rare Bone Disorders Using MEKANOS Tool. Case Study of Fibrous Dysplasia of Bone/McCune Albright SyndromeActive, not recruitingNCT075079421 country
- Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous DysplasiaCompletedNCT05509595Phase 21 country
- Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous DysplasiaCompletedNCT05419050Phase 21 country
- Interest of Serum Periostin Dosage in Patients With Bone Fibrous DysplasiaCompletedNCT02868645Not applicable1 country
- TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONECompletedNCT01791842Phase 21 country
- Epigenetic Regulation in Fibrous Dysplasia of Bone: mirDYS Study.CompletedNCT03838991Not applicable1 country
- Df-Life : Quality of Life in Patients With Fibrous DysplasiaCompletedNCT054065441 country
- A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.CompletedNCT049310561 country
- Determination of Circulating Autotaxin in Patients With GNAS or PTH AbnormalitiesCompletedNCT046717191 country
- Effectiveness of Medical Management of Fibrous Dysplasia of Bone.CompletedNCT054228331 country
- Denosumab Treatment for Fibrous DysplasiaActive, not recruitingNCT03571191Phase 21 country
- Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of BoneCompletedNCT00445575Phase 2/34 countries
- Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright SyndromeWithdrawnNCT035201531 country
- Effects of Letrozole on Precocious Puberty Due to McCune Albright SyndromeCompletedNCT00006174Phase 11 country
- Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright SyndromeCompletedNCT000019731 country
- Arimidex in McCune Albright SyndromeCompletedNCT00055302Phase 24 countries